Replacing refined grains with whole grains lowers all-cause mortality by 17% and coronary heart disease by 19%, while refined grains offer no protective benefit (archive interpretation of Aune 2016).

Original statement

ظهر أن استبدال الحبوب المكررة بالكاملة يخفض الوفاة لأي سبب بنسبة 17٪ وأمراض القلب التاجية بنسبة 19٪، بينما لم تظهر الحبوب المكررة أي فائدة وقائية على الإطلاق.

verbatim according to source. Translation by the project; the Arabic wording is authoritative.

Translation

Replacing refined grains with whole grains lowers all-cause mortality by 17% and coronary heart disease by 19%, while refined grains offer no protective benefit (archive interpretation of Aune 2016).

Origin

Source status

Archive editors

Attribution

Archive editors (study selection and narrative)

Origin

https://eltayebat.com/rule/refined-wheat/

Attribution uncertainty

Written by the archive operators; the study citations are the archive's, not shown to be Elawady's own.

Claimed mechanism

Fibre, bran and germ removed by milling.

Claimed health effect

Lower mortality and CHD with whole grains.

Population concerned

General population.

Geographic restriction by Elawady

none found

Scientific assessment

Mostly true – Correct at its core, but with limitations or minor inaccuracies.

Certainty of evidence: moderate – Further research may still affect the assessment.

1. What was claimed?

Whole grains instead of refined grains reduce death and CHD.

2. What is demonstrably correct?

Per 90 g/day whole grain: CHD RR 0.81 (0.75-0.87), CVD 0.78 (0.73-0.85), all-cause mortality 0.83 (0.77-0.90) (A-WHT-02). Reynolds 2019 found similar benefits for whole grain and fibre (I-WHT-01).

3. What is wrong or exaggerated?

The study did not model 'swapping': all estimates are per 90 g/day increment of whole grain. It also found 'little evidence of an association' for refined grains - meaning no harm, and in some dose-response analyses even weak inverse associations with total cancer and mortality - which the archive presents as one-sided. Observational associations are presented as effects ('cut').

4. What remains unclear?

Size of benefit attributable to whole grain itself versus healthier lifestyle of whole-grain eaters; short RCTs show modest effects on risk factors.

5. Which studies support it?

A-WHT-02, I-WHT-01, A-WHT-13, A-WHT-04.

6. Which studies contradict it?

None against the direction. Limitation: a Cochrane review found no RCT measuring cardiovascular events or mortality (I-WHT-110); RCTs show only modest effects on risk factors (I-WHT-111).

7. What applies to Germany and Europe?

Consistent with DGE and EU dietary guidance to prefer whole-grain products.

8. What is known about Egypt?

Whole-grain options (freekeh, whole-wheat bread, whole maize) are available; consistent with the system's allowance of freekeh and corn.

9. What practical conclusion is appropriate?

Prefer whole grains. This supports part of the system's direction, though not its mechanism.

Assessment details

Rationale for certainty of evidence

Whole-grain intake is consistently associated with lower CHD, CVD and mortality in prospective cohorts (A-WHT-02) and in the WHO-commissioned Lancet review (I-WHT-01; GRADE low to moderate for whole grains, moderate for fibre). Downgraded because the archive misstates the analysis: the 17%/19% figures are per 90 g/day increase in whole grain, not a substitution analysis, and the data are observational.

Source quality

A-WHT-02 is a high-quality dose-response meta-analysis; the archive's paraphrase ('swapping') is inaccurate.

Regional transferability

Mostly US/European cohorts; direction likely transferable.

Individual exceptions

People with coeliac disease must use gluten-free whole grains.

Regional scope of the claim

general (biological/medical)

Last reviewed

26 October 2026 provisional

Scientific evidence in detail

Scientifically well supported – The claim agrees with consistent, high-quality evidence.

Research question: Is higher whole-grain intake (in place of refined grains) associated with lower all-cause mortality and CHD, and do refined grains lack this benefit?

Study results as reported by the authors. Our assessment follows below.

Open questions

Long-term outcome trials.

How deeply was this checked?

8 linked studies: 1 checked in full text (1 of them with a structured risk-of-bias assessment), 7 on the basis of the abstract, 0 bibliographically only. No formal assessment with two independent reviewers and no independent human expert review has taken place yet.

Last scientific review: 26 October 2026

In plain language

Large reviews show that people who eat more whole grains, such as whole-wheat bread or freekeh, have fewer heart problems and live longer on average. The archive turns this into a precise promise ('swapping lowers death by 17%'), which the study did not test. The general advice to prefer whole grains is well supported. It does not prove that normal amounts of white bread are harmful.

Studies on this claim

Regional context

Germany / EU

Consistent with DGE and EU dietary guidance to prefer whole-grain products.

Egypt

Whole-grain options (freekeh, whole-wheat bread, whole maize) are available; consistent with the system's allowance of freekeh and corn.

What applies in my country?

General scientific assessment

Mostly true Whole grains are associated with clear health benefits; the archive overstates the precision and causality of the numbers.

The following areas of food safety are relevant to this statement:

• Pesticides and pesticide residues
• Contaminants (heavy metals, PFAS, PCBs, dioxins, nitrate)
• Mycotoxins (mould toxins)

Cereals and rice

Limits: legal rules describe what is allowed, not what every single food contains. Measurement data come from samples and are meaningful only together with their method details.

Country of residence or purchase Compare with another country

References

1. Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies.. Aune D et al.. BMJ 2016 · PMID 27301975 · DOI 10.1136/bmj.i2716
2. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses.. Reynolds A et al.. Lancet 2019 · PMID 30638909 · DOI 10.1016/S0140-6736(18)31809-9
3. Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review.. de Munter JS et al.. PLoS Med 2007 · PMID 17760498 · DOI 10.1371/journal.pmed.0040261
4. Consumption of whole grains and refined grains and associated risk of cardiovascular disease events and all-cause mortality: a systematic review and dose-response meta-analysis of prospective cohort studies.. Hu H et al.. Am J Clin Nutr 2023 · PMID 36789934 · DOI 10.1016/j.ajcnut.2022.10.010
5. Umbrella Review of Systematic Reviews and Meta-analyses on Consumption of Different Food Groups and Risk of All-cause Mortality.. Onni AT et al.. Adv Nutr 2025 · PMID 39956388 · DOI 10.1016/j.advnut.2025.100393
6. Whole grain cereals for the primary or secondary prevention of cardiovascular disease.. Kelly SA et al.. Cochrane Database Syst Rev 2017 · PMID 28836672 · DOI 10.1002/14651858.CD005051.pub3
7. Refined grain intake and cardiovascular disease: Meta-analyses of prospective cohort studies.. Gaesser GA. Trends Cardiovasc Med 2024 · PMID 36075506 · DOI 10.1016/j.tcm.2022.08.002
8. The Effect of Replacing Refined Grains with Whole Grains on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with GRADE Clinical Recommendation.. Marshall S et al.. J Acad Nutr Diet 2020 · PMID 32933853 · DOI 10.1016/j.jand.2020.06.021